• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

20/06/2018 by Intellectual Property Watch 15 Comments

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

The views expressed in this article are solely those of the authors and are not associated with Intellectual Property Watch. IP-Watch expressly disclaims and refuses any responsibility or liability for the content, style or form of any posts made to this forum, which remain solely the responsibility of their authors.

[Note: this article has been translated into French, Spanish, Portuguese, Russian and Thai, available here.]

Dr Carlos Maria Correa, an Argentinian economist and lawyer, is globally renowned for his expertise on international trade, intellectual property, health, technology transfer, investment policy and especially their impact on developing countries. He has authored several books and academic articles and been a visiting professor at several universities. Additionally, he has consulted with many United Nations agencies, the World Bank, and other regional and international organisations and has advised several governments on intellectual property, innovation policy and public health. Correa was a member of the UK Commission on Intellectual Property, of the Commission on Intellectual Property, Innovation and Public Health established by the World Health Assembly and of the FAO Panel of Eminent Experts on Ethics in Food and Agriculture.

Currently, he is the Director of the Centre for Interdisciplinary Studies on Industrial Property and Economics Law, at the University of Buenos Aires. He takes over as the Executive Director of the Secretariat of the Geneva-based South Centre from 1 July 2018. Correa recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is number two of two. The first, with Dr Othoman Mellouk, is available here.]

Intellectual Property Watch (IPW): Conventional wisdom has it that strong protection of intellectual property rights leads to development through the promotion of innovation. But does IPR have the same impact in all countries, irrespective of their level of development?

Carlos Correa

CARLOS CORREA (CORREA): The impact of IP, like of any other policy, is dependent on the particular context where it applies. The argument that IP will have the same effect regardless of the level of development is just illogical, an inadmissible simplification from a theoretical and practical point of view. For example, it seems evident that the incentive effect that IP may have regarding innovation will not be the same in countries with a diversified and advanced industrial structure and in those dependent on the production and trade of commodities.

IPW: How many of the key arguments premised on linking IPR with trade and innovation hold good and how many are myths?

CORREA: Any simplification about those links may be characterized as a ‘myth’. IP protection does not necessarily lead to more innovation or trade. It may have the opposite effect, for instance, if local companies at an early stage of technological development cannot enter certain markets, they will be prevented to move through the learning curve and upgrade technologically. Historical studies show that today developed countries advanced in their industrialization processes on the basis of lack of IP protection or flexible IP regimes. The US itself provides a good example in this regard.

IPW: How does one challenge the myths around IPR and trade and innovation? What role do you see for civil society, both at the local and global level, in countering the current challenges in this area and protecting public health and public interest?

CORREA: These myths can be solidly challenged on the basis of the wide body of academic literature on the subject, including general, sectoral and country studies. Literature has focused primarily on patent rights, but there are also studies on other aspects of IP. Public interest can be protected if the needs and policies of a particular country are properly assessed and demands (or pressures) to increase the level of IP protection are resisted. The recently adopted IP Policy by South Africa provides a good example of how a policy may be developed taking into account public interests rather than dogmatic views on the matter.

IPW: Many emerging economies like India, which are trying to attract foreign investment, are under tremendous pressure to buy into the argument that without a stringent IPR regime, TRIPS plus so to speak, foreign investment would not come in and this could derail their aspirations of boosting economic growth. Is there evidence that supports this line of thought.

CORREA: There is no evidence in this respect. FDI is primarily attracted by other factors, such as market size and expected growth, political stability, a functioning judicial system. India has had a steady economic growth and is today one of the biggest world economies. It also complies with the internationally accepted IP standards as contained in the TRIPS Agreement. There would be no real need to increase or expand IP protection to attract FDI.

IPW: Emerging economies like India are also keen on becoming innovation hubs. Simultaneously, there are public interest issues like the need to provide affordable medicines to millions of poor people. Given the current challenges, how does one balance innovation with IPR and public interest? What would be your advice to such countries?

CORREA: Each country has to define how to integrate IP into national policies. My advice would be to objectively study the situation and prospects in different sectors of the economy and the social implications of IP, and on that basis adopt suitable policies. Of course, the TRIPS Agreement sets out some limitations, but their effects might be mitigated by using the so-called ‘TRIPS flexibilities’, which are particularly important in the area of public health. It would also be important to acknowledge that a rational policy should aim at promoting both innovation and access to its outcomes, and that IP does not automatically lead to more or better innovation. The diffusion of knowledge and technologies is essential for progress in a society.

IPW: Thank you.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Creative Commons License"The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: Features, Inside Views, IP Policies, Themes, Venues, Development, English, Health & IP, Human Rights, Innovation/ R&D, Patents/Designs/Trade Secrets, Supported By, TRIPS Flexibilities, Technical Cooperation/ Technology Transfer, United Nations - other, WTO/TRIPS

Trackbacks

  1. The Myth Behind Health And Trade Agreements - Q&A With Othoman Mellouk - Intellectual Property Watch says:
    15/07/2018 at 6:38 pm

    […] Dr Othoman Mellouk is a Moroccan treatment advocate who has been working on intellectual property and access to medicines for more than a decade. He is the Intellectual Property and Access to Medicines Lead at the international treatment preparedness coalition (ITPC), a global network of people living with HIV and their advocates working together to achieve access to HIV and Viral Hepatitis and a member of the WHO Strategic and Technical Advisory Committee on HIV and Hepatitis. Dr Mellouk started off in the Association for the Fight against AIDS which has been at the forefront of the response to HIV in Morocco and the introduction of the first anti-HIV generic medicines in the country. In a series supported by the Make Medicines Affordable organisation, Mellouk recently engaged in an interview with Patralekha Chatterjee for Intellectual Property Watch. [Note: this interview is one of two. The first, an interview with Carlos Correa, is here.] […]

    Reply
  2. India’s IP Policy: A Bare Act? | SpicyIP says:
    01/08/2018 at 7:11 am

    […] 2018, our policy falls short on several counts. As Prof. Carlos Correa rightly stated in a recent interview in the iconoclastic IP Watch: “The recently adopted IP Policy by South Africa provides a good […]

    Reply
  3. De-Coding Indian Intellectual Property Law | Kractivism says:
    02/08/2018 at 2:24 pm

    […] 2018, our policy falls short on several counts. As Prof. Carlos Correa rightly stated in a recent interview in the iconoclastic IP Watch: “The recently adopted IP Policy by South Africa provides a good […]

    Reply
  4. Le mythe des droits de propriété intellectuelle comme mesures incitatives pour toutes les nations — Entretien avec Carlos Correa - Intellectual Property Watch says:
    09/08/2018 at 7:46 pm

    […] [View the original English version here.] […]

    Reply
  5. El mito de los incentivos en materia de propiedad intelectual para todas las naciones. Preguntas y respuestas con Carlos Correa - Intellectual Property Watch says:
    09/08/2018 at 7:53 pm

    […] [View the original English version here.] […]

    Reply
  6. O Mitos da propriedade intelectual como incentivo para todas as nações – Perguntas e Respostas com Carlos Correa - Intellectual Property Watch says:
    09/08/2018 at 8:36 pm

    […] [View the original English version here.] […]

    Reply
  7. Le mythe du lien entre la santé et les accords de libre-échange — Entretien avec Othoman Mellouk - Intellectual Property Watch says:
    09/08/2018 at 9:01 pm

    […] Le 18 juin 2018 – Othoman Mellouk est un défenseur marocain de l’accès aux traitements dont le travail porte depuis plus de dix ans sur la propriété intellectuelle et l’accès aux médicaments. Il est responsable des questions de propriété intellectuelle en lien avec l’accès aux médicaments au sein de la Coalition internationale pour la préparation au traitement (ITPC), un réseau mondial qui regroupe des personnes touchées par le VIH et leurs défenseurs et qui agit pour l’accès aux médicaments contre le VIH et l’hépatite virale. Il est également membre du Comité consultatif technique et stratégique sur l’hépatite virale et le VIH, un organe de l’OMS. Dans le cadre d’un dossier spécial soutenu par Make Medicines Affordable, M. Mellouk a récemment accepté un entretien avec Patralekha Chatterjee pour Intellectual Property Watch. [Nous vous proposons deux entretiens sur le même thème, celui-ci étant le premier. Le second, avec Carlos Correa, est disponible ici.] […]

    Reply
  8. IP-Watch Q&A with Carlos Correa: The myth of IP incentives for all nations - Make Medicines Affordable says:
    10/08/2018 at 3:00 pm

    […] Original version first published on IP-Watch. Author: Patrelekha Chatterjee. […]

    Reply
  9. Миф о стимулах в сфере ИС для всех стран — интервью с Карлосом Корреа says:
    14/08/2018 at 12:10 am

    […] [View the original English version here.] […]

    Reply
  10. เรื่องแต่งเกี่ยวกับแรงจูงใจในการสร้างทรัภsays:
    14/08/2018 at 1:54 am

    […] [View the original English version here.] […]

    Reply
  11. Le mythe des droits de propriété intellectuelle comme mesures incitatives pour toutes les nations — Entretien avec Carlos Correa - Make Medicines Affordable says:
    16/08/2018 at 12:09 pm

    […] [View the original English version here, article by IP-WATCH.] […]

    Reply
  12. El mito de los incentivos en materia de propiedad intelectual para todas las naciones. Preguntas y respuestas con Carlos Correa - Make Medicines Affordable says:
    16/08/2018 at 12:10 pm

    […] [View the original English version here, article by IP-WATCH.] […]

    Reply
  13. O Mitos da propriedade intelectual como incentivo para todas as nações – Perguntas e Respostas com Carlos Correa - Make Medicines Affordable says:
    16/08/2018 at 12:11 pm

    […] [View the original English version here, article by IP-WATCH.] […]

    Reply
  14. เรื่องแต่งเกี่ยวกับแรงจูงใจในการสร้างทรัภsays:
    16/08/2018 at 12:14 pm

    […] [View the original English version here, article by IP-WATCH.] […]

    Reply
  15. Civil Society And TRIPS Flexibilities Series - Translations Now Available - Intellectual Property Watch says:
    20/08/2018 at 2:45 pm

    […] The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa […]

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2022 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.